Health-related quality-of-life assessment and planning for the pharmaceutical industry

scientific article published on September 1997

Health-related quality-of-life assessment and planning for the pharmaceutical industry is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/S0149-2918(97)80063-X
P698PubMed publication ID9385497

P2093author name stringRevicki DA
Ehreth JL
P2860cites workA quantitative approach to perceived health status: a validation studyQ24518621
Shattuck lecture--outcomes management. A technology of patient experienceQ34176377
Preferences for health outcomes. Comparison of assessment methodsQ34256051
Quality of life, health status, and clinical researchQ38606692
Methodology for measuring health-state preferences--III: Population and context effectsQ38652675
Health status measures: an overview and guide for selectionQ39767575
Psychometric considerations in evaluating health-related quality of life measuresQ40742458
Methods for assessing relative importance in preference based outcome measuresQ40742469
Managed care pharmacy, socioeconomic assessments and drug adoption decisionsQ40886683
The validity of proxy-generated scores as measures of patient health status.Q52052131
STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.Q52137534
The Sickness Impact Profile: Development and Final Revision of a Health Status MeasureQ55063071
Linking clinical variables with health-related quality of life. A conceptual model of patient outcomesQ58723572
Relationship between health utility and psychometric health status measuresQ68122497
Incorporating utility-based quality-of-life assessment measures in clinical trials. Two examplesQ69294974
Utilities and quality-adjusted life yearsQ69463744
Methodology for measuring health-state preferences--I: Measurement strategiesQ69614383
Methodology for measuring health-state preferences--II: Scaling methodsQ69629874
A methodological framework for assessing health indicesQ70061009
Chronic disease, function and the quality of careQ70830221
The view from managed care pharmacyQ71963514
Responsiveness and calibration of the General Well-Being Adjustment Scale in patients with hypertensionQ72192229
P433issue5
P921main subjectquality of lifeQ13100823
P304page(s)1101-1115
P577publication date1997-09-01
P1433published inClinical TherapeuticsQ15716601
P1476titleHealth-related quality-of-life assessment and planning for the pharmaceutical industry
P478volume19

Reverse relations

cites work (P2860)
Q35483470A comparison of health utility measures for the evaluation of multiple sclerosis treatments
Q34941312A staging approach to measuring patient-centred subjective outcomes.
Q30965669EMEA and the evaluation of health-related quality of life data in the drug regulatory process
Q30658672Electronic collection of health-related quality of life data: validity, time benefits, and patient preference
Q35100282Health-related quality of life and regulatory issues in the US and Canada
Q37609270Impact of antipsychotic agents and their side effects on the quality of life in schizophrenia
Q35208797Patient-reported outcomes (PRO's) in glaucoma: a systematic review
Q34205886Recommendations on health-related quality of life research to support labeling and promotional claims in the United States
Q34268284Symptom and health-related quality-of-life measures for use in selected gastrointestinal disease studies: a review and synthesis of the literature
Q35177334The impact of treatment for gastro-oesophageal reflux disease on health-related quality of life: a literature review